TY - JOUR
T1 - Central serous chorioretinopathy after bone marrow transplantation
AU - Fawzi, Amani A.
AU - Cunningham, Emmett T.
N1 - Funding Information:
Supported by a Career Development Award from Research to Prevent Blindness, Inc., New York (Dr. Emmett T. Cunningham, Jr).
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - PURPOSE: To describe central serous chorioretinopathy after bone marrow transplantation. METHODS: The medical records of the patient were reviewed retrospectively. RESULTS: A 46-year-old Filipino man developed multifocal central serous chorioretinopathy affecting his left eye 4 months after bone marrow transplantation for acute myelogenous leukemia. Other co-existing medical problems at the time of presentation included systemic hypertension and graft-versus-host-disease (GVHD), for which the patient was using both systemic corticosteroids and cyclosporine. CONCLUSION: Central serous chorioretinopathy is a rare cause of vision loss in patients after bone marrow transplantation. Previous descriptions of bone marrow transplantation-associated central serous chorioretinopathy in patients with thrombotic microangiopathy, as well as the occurrence of both systemic hypertension and the use of systemic corticosteroids and cyclosporine in our patient with bone marrow transplantation-associated central serous chorioretinopathy, support theories of choroidal vascular compromise in the pathogenesis of central serous chorioretinopathy.
AB - PURPOSE: To describe central serous chorioretinopathy after bone marrow transplantation. METHODS: The medical records of the patient were reviewed retrospectively. RESULTS: A 46-year-old Filipino man developed multifocal central serous chorioretinopathy affecting his left eye 4 months after bone marrow transplantation for acute myelogenous leukemia. Other co-existing medical problems at the time of presentation included systemic hypertension and graft-versus-host-disease (GVHD), for which the patient was using both systemic corticosteroids and cyclosporine. CONCLUSION: Central serous chorioretinopathy is a rare cause of vision loss in patients after bone marrow transplantation. Previous descriptions of bone marrow transplantation-associated central serous chorioretinopathy in patients with thrombotic microangiopathy, as well as the occurrence of both systemic hypertension and the use of systemic corticosteroids and cyclosporine in our patient with bone marrow transplantation-associated central serous chorioretinopathy, support theories of choroidal vascular compromise in the pathogenesis of central serous chorioretinopathy.
UR - http://www.scopus.com/inward/record.url?scp=0035014608&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035014608&partnerID=8YFLogxK
U2 - 10.1016/S0002-9394(00)00928-4
DO - 10.1016/S0002-9394(00)00928-4
M3 - Article
C2 - 11384585
AN - SCOPUS:0035014608
SN - 0002-9394
VL - 131
SP - 804
EP - 805
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 6
ER -